Back to search

Article

Restructuring of the Immune Contexture Improves Checkpoint Blockade Efficacy in Murine Lung Cancer

2020-10-10

Abstract excerpt

<h4>ABSTRACT</h4> Therapeutic options for non-small cell lung cancer (NSCLC) treatment have changed dramatically in recent years with the advent of novel immunotherapeutic approaches. Among these, immune checkpoint blockade (ICB), using monoclonal antibodies, has shown tremendous promise in a small proportion of patients. In order to better predict patients that will respond to ICB treatment, biomarkers such as t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eec633f9-a0b6-5a88-b26c-df39988a8362
DOI
10.1101/2020.10.09.332387
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Restructuring of the Immune Contexture Improves Checkpoint Blockade Efficacy in Murine Lung CancerDOI 10.1101/2020.10.09.332387
Select a neighboring publication to make it the new centre.